Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gorovets

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|June 2, 2015
Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastasesDaniel Gorovets, Paul Rava, Daniel K Ebner, et al.
Practical Radiation Oncology|June 29, 2019
Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR SimulationKristen L Zakian, Andreas Wibmer, Hebert A Vargas, et al.
Advances in Radiation Oncology|May 22, 2023
Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity OutcomesCraig E Grossman, Michael R Folkert, Stephanie Lobaugh, et al.
Advances in Radiation Oncology|December 11, 2020
Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate CancerBrandon S Imber, Melissa Varghese, Debra A Goldman, et al.
BJU International|August 13, 2021
Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicityAchiraya Teyateeti, Craig Grossman, Marisa A Kollmeier, et al.
Journal of Clinical Medicine|May 4, 2026
Trends in Primary- and Metastasis-Directed Radiotherapy Uptake and Survival in Metastatic Prostate CancerJames O Suggitt, Tej A Patel, Miranda B Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2012
IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic gliomaDaniel Gorovets, Kasthuri Kannan, Ronglai Shen, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder CancerAssaf Moore, Stephanie M Lobaugh, Zhigang Zhang, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2013
Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomasSriram Venneti, Michelle Madden Felicella, Thomas Coyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2021
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapyMichael J Zelefsky, Debra A Goldman, Margaret Hopkins, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|June 2, 2015
Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastasesDaniel Gorovets, Paul Rava, Daniel K Ebner, et al.
Practical Radiation Oncology|June 29, 2019
Comparison of Motion-Insensitive T2-Weighted MRI Pulse Sequences for Visualization of the Prostatic Urethra During MR SimulationKristen L Zakian, Andreas Wibmer, Hebert A Vargas, et al.
Advances in Radiation Oncology|May 22, 2023
Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity OutcomesCraig E Grossman, Michael R Folkert, Stephanie Lobaugh, et al.
Advances in Radiation Oncology|December 11, 2020
Clinical Outcomes of Combined Prostate- and Metastasis-Directed Radiation Therapy for the Treatment of De Novo Oligometastatic Prostate CancerBrandon S Imber, Melissa Varghese, Debra A Goldman, et al.
BJU International|August 13, 2021
Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicityAchiraya Teyateeti, Craig Grossman, Marisa A Kollmeier, et al.
Journal of Clinical Medicine|May 4, 2026
Trends in Primary- and Metastasis-Directed Radiotherapy Uptake and Survival in Metastatic Prostate CancerJames O Suggitt, Tej A Patel, Miranda B Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2012
IDH mutation and neuroglial developmental features define clinically distinct subclasses of lower grade diffuse astrocytic gliomaDaniel Gorovets, Kasthuri Kannan, Ronglai Shen, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder CancerAssaf Moore, Stephanie M Lobaugh, Zhigang Zhang, et al.
Journal of Neuropathology and Experimental Neurology|March 14, 2013
Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomasSriram Venneti, Michelle Madden Felicella, Thomas Coyne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 15, 2021
Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapyMichael J Zelefsky, Debra A Goldman, Margaret Hopkins, et al.
Pageof 5